Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection

13Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Aim: A discrimination analysis has been explored for the probabilistic classification of healthy versus ovarian cancer serum samples using proteomics data from mass spectrometry (MS). Methods: The method employs data normalization, clustering, and a linear discriminant analysis on surface-enhanced laser desorption ionization (SELDI) time-of-flight MS data. The probabilistic classification method computes the optimal linear discriminant using the complex human blood serum SELDI spectra. Cross-validation and training/testing data-split experiments are conducted to verify the optimal discriminant and demonstrate the accuracy and robustness of the method. Results: The cluster discrimination method achieves excellent performance. The sensitivity, specificity, and positive predictive values are above 97% on ovarian cancer. The protein fraction peaks, which significantly contribute to the classification, can be available from the analysis process. Conclusion: The discrimination analysis helps the molecular identities of differentially expressed proteins and peptides between the healthy and ovarian patients. © 2008 CPS and SIMM.

Cite

CITATION STYLE

APA

Hong, Y. J., Wang, X. D., Shen, D., & Zeng, S. (2008). Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection. Acta Pharmacologica Sinica, 29(10), 1240–1246. https://doi.org/10.1111/j.1745-7254.2008.00861.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free